Published in

American Association for the Advancement of Science, Science Translational Medicine, 496(11), 2019

DOI: 10.1126/scitranslmed.aax4738

Links

Tools

Export citation

Search in Google Scholar

Twists and turns to translating 4-1BB cancer immunotherapy

Journal article published in 2019 by Miguel F. Sanmamed, Iñaki Etxeberría ORCID, Itziar Otano ORCID, Ignacio Melero ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Previous shortcomings of CD137-targeted immunotherapy may be overcome by engineered bispecific agents (Claus et al ., this issue).